1. Patterns of cerebral glucose utilisation in Parkinson's disease and Huntingdon's disease;DE, I.Kuhl; EJ, Metter; WH, Riege; CH, Markham;Ann Neurol; 15: Sl 19-S 125,1984
2. Similarities of cerebral glucose metabolism in Alzheimer's and Parkinsonian dementia;Kuhl, D.E.; Metter, E.J.; Benson, D.F.;J Cereb Blood Flow Metabol,1985
3. LCMRGlu in untreated and treated Parkinson's disease;Rougemont, D.; Baron, J.C.; Collard, P.;J Cereb Blood Flow Metabol,1983
4. Metabolic effects of unilateral lesions of the substantia nigra;Wooten, G.F.; Collins, R.C.;J Neurosci,1981
5. Contralateral basal ganglia metabolism is abnormal in hemiparkinsonian patients. An FDG-PET study;Miletich, R.S.; Chan, T.; Gillespie, M.; Di Chiro, G.; Stein, S.;Neurology,1988